Taiko Pharmaceutical Co (TSE:4574) Cyclically Adjusted Book per Share: 円360.11 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4574 Taiko Pharmaceutical Co Ltd TSE:4574
64 GF Score
Price 円276.00
GF Value 円352.09
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Taiko Pharmaceutical Co Cyclically Adjusted Book per Share?

Taiko Pharmaceutical Co TSE:4574 +3.37% 64 Cyclically Adjusted Book per Share is 円360.11 as of Dec. 2025. GuruFocus rates TSE:4574 with a GF Score™ of 64/100 and a GF Value™ of 円352.09 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Taiko Pharmaceutical Co's adjusted book value per share for the three months ended in Dec. 2025 was 円169.509. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is 円360.11 for the trailing ten years ended in Dec. 2025.

During the past 12 months, Taiko Pharmaceutical Co's average Cyclically Adjusted Book Growth Rate was -3.40% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -1.30% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 1.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Taiko Pharmaceutical Co was 6.50% per year. The lowest was -1.30% per year. And the median was 2.70% per year.

As of today (2026-07-15), Taiko Pharmaceutical Co's current stock price is 円276.00. Taiko Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2025 was 円360.11. Taiko Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is 0.77.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Taiko Pharmaceutical Co was 8.68. The lowest was 0.66. And the median was 1.63.


Taiko Pharmaceutical Co  (TSE:4574) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Taiko Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=276.00/360.11
=0.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Taiko Pharmaceutical Co was 8.68. The lowest was 0.66. And the median was 1.63.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Taiko Pharmaceutical Co Cyclically Adjusted Book per Share Related Terms


Taiko Pharmaceutical Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Taiko Pharmaceutical Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Taiko Pharmaceutical Co Cyclically Adjusted Book per Share Chart

Taiko Pharmaceutical Co Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 362.47 374.46 371.67 372.73 360.11

Taiko Pharmaceutical Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 369.17 365.83 361.84 360.11 0.00

TSE:4574 vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Taiko Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Taiko Pharmaceutical Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Taiko Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Taiko Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


TSE:4574
64GF Score
Taiko Pharmaceutical Co Ltd TSE:4574
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Taiko Pharmaceutical Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Taiko Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Dec. 2025 was:

Adj_Book= Book Value per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=169.509/113.0000*113.0000
=169.509

Current CPI (Dec. 2025) = 113.0000.

Taiko Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201512 336.050 98.100 387.091
201603 336.175 97.900 388.026
201606 328.447 98.100 378.333
201609 364.434 98.000 420.215
201612 388.787 98.400 446.473
201703 363.170 98.100 418.330
201706 358.375 98.500 411.131
201709 362.685 98.800 414.812
201712 384.543 99.400 437.157
201803 384.425 99.200 437.903
201806 376.275 99.200 428.620
201809 387.137 99.900 437.903
201812 403.699 99.700 457.553
201903 406.337 99.700 460.542
201906 397.938 99.800 450.571
201909 407.385 100.100 459.885
201912 440.216 100.500 494.969
202003 451.271 100.300 508.411
202006 481.322 99.900 544.438
202009 511.067 99.900 578.084
202012 525.932 99.300 598.493
202103 506.404 99.900 572.809
202106 459.920 99.500 522.321
202109 469.978 100.100 530.545
202112 293.821 100.100 331.686
202203 254.996 101.100 285.010
202206 233.611 101.800 259.313
202209 225.282 103.100 246.914
202212 184.574 104.100 200.354
202303 179.847 104.400 194.662
202306 192.466 105.200 206.736
202309 197.288 106.200 209.920
202312 134.895 106.800 142.726
202403 148.016 107.200 156.024
202406 160.856 108.200 167.992
202412 158.644 110.700 161.940
202503 158.963 111.100 161.682
202506 158.166 111.700 160.007
202509 163.897 112.000 165.360
202512 169.509 113.000 169.509

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of 円360.11 mean?
Taiko Pharmaceutical Co (TSE:4574) has a Cyclically Adjusted Book per Share of 円360.11 as of Dec. 2025. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Taiko Pharmaceutical Co and its competitors.
Is Taiko Pharmaceutical Co's Cyclically Adjusted Book per Share too high?
Taiko Pharmaceutical Co's current Cyclically Adjusted Book per Share is 円360.11. Overall, Taiko Pharmaceutical Co has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Taiko Pharmaceutical Co's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Taiko Pharmaceutical Co's Cyclically Adjusted Book per Share of 円360.11 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Taiko Pharmaceutical Co and its competitors. Taiko Pharmaceutical Co's current Cyclically Adjusted Book per Share is 円360.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Taiko Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Taiko Pharmaceutical Co (TSE:4574) is currently considered Modestly Undervalued. The stock's GF Value™ is 円352.09, compared to a current price of 円276.00 — trading 21.6% below its estimated fair value. The current Cyclically Adjusted Book per Share is 円360.11. Taiko Pharmaceutical Co's overall GF Score™ is 64/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Taiko Pharmaceutical Co (TSE:4574), the current Cyclically Adjusted Book per Share is 円360.11 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Taiko Pharmaceutical Co (TSE:4574) Overvalued in 2026?

Based on GuruFocus' analysis, Taiko Pharmaceutical Co stock appears to be undervalued. The current stock price of 円276.00 is trading 21.6% below its estimated GF Value™ of 円352.09. GuruFocus considers Taiko Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for TSE:4574:

  • Cyclically Adjusted Book per Share: 円360.11
  • GF Value™: 円352.09 vs. price of 円276.00 (21.6% below fair value)
  • GF Score™: 64/100 with 3 warning signs

No single metric tells the full story. See the TSE:4574 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Taiko Pharmaceutical Co Business Description

Address 1-4-1 Nishihonmachi, 16th Floor, ORIX Honmachi Building, Nishi-ku, Osaka, JPN, 564-0032
Taiko Pharmaceutical Co Ltd operates in three segments, namely Pharmaceutical, Infection Control, and Others. The majority of its revenue comes from Infection Control, which is into manufacturing and sales of sanitation control products, including Cleverin, Cleverin LED, and Cleverin Generator LISPASS. The pharmaceutical segment is into the manufacturing and sales of OTC medicines and designated quasi-drugs. Other business includes manufacturing and sales of wood vinegar-based products.
64GF Score

Get the complete analysis for TSE:4574

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円276.00
Price
円352.09
GF Value